29th March 2019 Rosie Baur
Prescribing in Cancer and End of Life
Ashford Clinical Commissioning Group, Canterbury and Coastal Clinical Commissioning Group, South Kent Coast Clinical Commissioning Group and Thanet Clinical Commissioning Group.
Prescribing in Cancer and End of Life 29 th March 2019 Rosie Baur - - PowerPoint PPT Presentation
Prescribing in Cancer and End of Life 29 th March 2019 Rosie Baur Ashford Clinical Commissioning Group, Canterbury and Coastal Clinical Commissioning Group, South Kent Coast Clinical Commissioning Group and Thanet Clinical Commissioning Group.
Ashford Clinical Commissioning Group, Canterbury and Coastal Clinical Commissioning Group, South Kent Coast Clinical Commissioning Group and Thanet Clinical Commissioning Group.
to assess for lung cancer in people aged 40 and over if they have 2 or more of the following unexplained symptoms, or if they have ever smoked and have 1 or more of the following unexplained symptoms:
follow this up?
first consultation or before with new urology co-ordinators)
prostate involving seminal vesicles and 2 enlarged lymph nodes 12 and 14mm (above 10mm we would call as nodal positive), nodes also show on CT so stage is T3b N1 M0
to prescribe and has said that he needs to start hormones, be discussed in MDM and see oncology to discuss addition of Radiotherapy, referral has been made.
days before stopping altogether.
switching to a 3 month dose if the monthly dose tolerated.
grade prostate cancer with disease spread and the nurse explained that when he starts hormones the prostate cancer will start to come under control.